Mirum Pharmaceuticals, Inc. Tech Stack
Biopharmaceutical company commercializing rare-disease treatments across three approved medicines
Mirum is a public biopharmaceutical company with three FDA-approved medications for rare liver and metabolic diseases, now scaling commercial and regulatory operations. The hiring acceleration—36 roles posted in the last 30 days across sales, healthcare, and market access—reflects active label-expansion studies (EXPAND for LIVMARLI) and pipeline advancement. The tech stack is clinical-stage heavy (Veeva QMS, Electronic Data Capture, LC-MS/MS, CDISC, SAS) paired with commercial tools (Salesforce, Veeva), signaling simultaneous focus on manufacturing compliance and revenue growth.
Tech Stack 21 technologies
What Mirum Pharmaceuticals, Inc. Is Building
◆Challenges
- Access challenges
- Complex rare disease patient journeys
- Timely delivery of regulatory submissions
- Improving diagnosis rates
- Ensuring compliant engagement with external experts
- Growing sales
- Ensuring global regulatory compliance
- Talent gaps
- Managing global supply chain
- Ensuring inventory alignment
▲Active Projects
- Supporting hepatology and gastroenterology community
- Advisory boards
- Marketing strategy for conferences and congresses
- Technical transfers and process development
- Regulatory submissions
- Market access strategy development
- Scientific symposia
- Commercial advisory board coordination
- Clinical development programs for rare diseases
- End-to-end launch excellence
Hiring Activity
Department
Seniority
Notable leadership hires: IT Integration Lead, Market Access Director, FP&A Director, Sales Director, Associate Director, Publications